Outcome of combined bevacizumab and irinotecan for patients with progressive brain metastases from non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Brosnan, Evelyn M.
Fadul, Camilo E.
Dragnev, Konstantin H.
Davis, Melissa C.
Shah, Khushboo A.
Eskey, Clifford J.
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Dartmouth Hitchcock Medcl Ctr, Lebanon, NH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19059
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Management of brain metastases from non-small cell lung cancer
    Baykara, Meltem
    Kurt, Gokhan
    Buyukberber, Suleyman
    Demirci, Umut
    Ceviker, Necdet
    Algin, Efnan
    Coskun, Ugur
    Aykol, Sukru
    Emmez, Hakan
    Ozet, Ahmet
    Benekli, Mustafa
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) : 915 - 921
  • [32] Bevacizumab Plus Radiosurgery for Nonsquamous Non-Small Cell Lung Cancer Patients with Brain Metastases: Safe Combination?
    Guinde, Julien
    Carron, Romain
    Tomasini, Pascale
    Greillier, Laurent
    Regis, Jean
    Barlesi, Fabrice
    WORLD NEUROSURGERY, 2017, 107 : 1047.e1 - 1047.e4
  • [33] Safety of Bevacizumab in Patients With Non-Small-Cell Lung Cancer and Brain Metastases
    Socinski, Mark A.
    Langer, Corey J.
    Huang, Jane E.
    Kolb, Margaret M.
    Compton, Peter
    Wang, Lisa
    Akerley, Wallace
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5255 - 5261
  • [34] Correlation between lung mass size in non-small cell lung cancer (NSCLC) and brain metastases
    Aziz, H
    Blamoun, A
    Shubair, M
    Ismail, MM
    Khan, MA
    CHEST, 2005, 128 (04) : 334S - 334S
  • [35] Efficacy and safety of bevacizumab in nonsquamous non-small cell lung cancer with brain metastases.
    Ichiki, Masao
    Yoshida, Tsukasa
    Nakamura, Masayuki
    Kumano, Tomomi
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Radiographic parameters in predicting outcome of patients with nonsquamous non-small cell lung cancer (NSCLC) treated with bevacizumab.
    Kaufman, Michael R.
    Salem, Mohamed E.
    Aoun, Hussein
    Kalemkerian, Gregory Peter
    Kunz, Sara
    El-Refai, Sherif
    Ranganath, Praveen
    Sukari, Ammar
    Gadgeel, Shirish M.
    Wozniak, Antoinette J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Detection of bone metastases in non-small cell lung cancer (NSCLC).
    Irving, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 663S - 663S
  • [38] Prevalence of KRAS Subtype Alterations in Non-Small Cell Lung Cancer (NSCLC) with Brain Metastases
    Karim, N. Abdel
    Polani, F.
    Se, B.
    Macera, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S246 - S246
  • [39] Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer
    She, Chunhua
    Wang, Ruixia
    Lu, Changhong
    Sun, Zengfeng
    Li, Peng
    Yin, Qiang
    Liu, Qun
    Wang, Peng
    Li, Wenliang
    THORACIC CANCER, 2019, 10 (02) : 137 - 142
  • [40] BEVACIZUMAB FOR ACTIVE BRAIN METASTASES FROM NON-SMALL-CELL LUNG CANCER
    DeBraganca, Kevin C.
    Ney, Douglas E.
    Kris, Mark G.
    Nolan, Craig P.
    Lassman, Andrew B.
    NEURO-ONCOLOGY, 2009, 11 (05) : 626 - 627
12345